Transfection of murine metastatic B78H1 cells (derived from B16 melanoma) with a syngeneic H-2Kb gene was used to study the 
The malignancy of tumour cells can be affected by alterations of major histocompatibility complex (MHC) class I glycoprotein expression (Wallich et al., 1985; Tanaka et al., 1988; Elliott et al., 1989; Gopas et al., 1989) . In particular it is known that T lymphocytes do not interact with MHCnegative cells (Doherty et al., 1984) and it has been hypothesised that natural killer cells selectively recognise MHC-negative cells (Llunggren & Karre, 1990) .
It has been suggested that MHC molecules might play a role also in phenomena not mediated by the immune system, such as cell proliferation (Gattoni-Celli et al., 1989; Sunday et al., 1989) and cell-cell interactions (Haliotis et al., 1990) .
We have previously observed that H-2 negative cells transfected with a syngeneic H-2Kb gene showed a greatly reduced metastatic ability in mice. This effect was not fully explained by immune-mediated properties of transfectants; other causes might contribute to the strong decrease in metastatic ability, as shown by the correlation with a reduced homotypic adhesion (De Giovanni et al., 1991) .
Tumour cell adhesion to extracellular matrix and to endothelial cells appears to be an important step in metastasis formation. A correlation between metastatic ability in vivo and adhesive behaviour in vitro of tumour cells has been reported by different groups (Nicolson, 1982; Varani et al., 1985; Korach et al., 1986; Auerbach et al., 1987; Humphries et al., 1988; Belloni & Tressler, 1989; Giavazzi et al., 1990) . Therefore in the present study we investigated whether transfection of a MHC gene could lead to alterations in adhesive ability of tumour cells to vascular endothelium and subendothelial components.
To study the effect of MHC gene products on tumour cell adhesion and the relation with metastatic ability, we used H-2Kb_positive transfectants and control clones (transfected with pSV2neo gene only) obtained from a murine melanoma clone (derived from B16 cell line) showing no class I H-2b expression (De Giovanni et al., 1991) .
Materials and methods
Tumour cells B78H1 is an amelanotic clone originally obtained in the laboratory of S. Silagi from B16 melanoma (Graf et al., 1984) ; it shows no H-2 expression even after interferon-'y treatment. The derivation of control (transfected with pSV2neo gene encoding resistance to the neomycin analogue G418) and H-2Kb transfectants has been described previously (De Giovanni et al., 1991) .
In the present study, H-2-negative B78H1 and four control clones were compared to five H-2Kb transfectants, one of which (Kb-G56) showed a poor, even though interferoninducible, (Dejana et al., 1987) , were routinely characterised by immunofluorescence techniques using rabbit anti-human factor VIII antigen (Behringwerke, AG, Marburg, Germany) (Balconi & Dejana, 1986; Dejana et al., 1989) . The cells were cultured in medium 199 (M 199) supplemented with 20% FCS, 50 jig ml-' endothelial cell growth supplement (prepaed from bovine brain), 100 tg ml-' heparin (Sigma Chemical Co., St. Louis, MO, USA), 50 U ml-1 penicillin, 50 tg ml-' streptomycin, 2.5 tLg ml-' fungizone at 37°C. All culture reagents were purchased from Gibco Europe, Paisley, Scotland. Tissue culture plates and flasks were obtained from Falcon (Becton Dickinson, Plymouth, UK).
Adhesion assay Murine endothelial cell lines grown to confluent monolayers in 96 well plates were washed twice with fresh DMEM containing 15% FCS. The same procedure was utilised in the experiments on HEC using M199 plus 20% FCS. In these experiments HEC were also activated with 20 U ml-' of human recombinant interleukin-i,I (specific activity I0 U fLg-'; Sclavo, Siena, Italy).
In other experiments, tumour cell adhesion to endothelial cell matrix or to extracellular matrix proteins (fibronectin, vitronectin and laminin) was studied. Subendothelial matrix was exposed by washing endothelial cell monolayers with PBS without Ca2+/Mg2+ and subsequent incubation with 5 mM EGTA in PBS without Ca2+/Mg2+ for 10 min. Endothelial cell detachment was assessed by light microscopy. The exposed matrix was then washed twice with PBS before adhesion. Fibronectin, vitronectin and laminin were prepared and used for coating the adhesion plate wells at 4°C overnight as described (Lampugnani et al., 1991 In some experiments, adhesion assay was performed also in the presence of the following neutralising antibodies. Anti-ICAM-1 mAb 6.5BS (Wellicome et al., 1990) , obtained through the courtesy of Dr Haskard (Hammersmith Hospital, London); the antibody, in the form of supernatant, was used at 1:20 dilution. Anti-VCAM-l (B) 4B9 was a nice gift of Dr Harlan (Carlos et al., 1990) ; the antibody in the form of purified IgG was used at lOtLgmlm'. Anti-Pl goat antiserum, described above, has been used at 1:100 dilution. These concentrations of the antibodies have been selected since they gave maximal inhibition in the appropriate assays as specified in the respective references.
Mice and in vivo treatments C57BL/6AnNCrlBR (referred to as C57BL/6) male mice were purchased from Charles River, Calco, Italy. Experimental lung metastases were counted 28 days after the intravenous (i.v.) injections of 5 x 105 B78H1 or transfectant cells. suspended in PBS into a lateral tail vein of 8-12 week-old mice. Lung nodules produced by amelanotic cells were contrasted with black India ink as described (Wexler, 1966) . All metastasis counts were performed on dissected lung lobes under a stereoscopic microscope.
Statistical analysis Statistical analysis was performed by Student's t-test (cell adhesion experiments) and by the non-parametric Wilcoxon test (experimental metastasis study).
Results
A greatly reduced metastatic ability of H-2Kb transfected cells has been reported in a previous paper (De Giovanni et al., 1991) , where some of the clones hereafter studied were characterized. For the present study, a wider panel of H-2Kb transfectants (referred to as 'Kb' clones) and control clones (transfected with pSVneo alone, 'Neo' clones) has been used. H-2Kb expression (Figure 1 ) and metastatic ability (Table I) of all the clones used throughout the study is reported for comparison. Four H-2Kb-expressing transfectants and a Kb clone (Kb-G56) with a poor basal H-2Kb expression ( Figure  1 ) were compared to H-2Kb-negative parental B78H1 cells and to four control 'Neo' clones. The experimental metastatic capacity of Kb clones was strikingly reduced in comparison to Neo controls as reported (Table I) .
We examined adhesion of parental, Neo and H-2Kb transfected melanoma clones to murine endothelial cells (bEnd). As shown in Figure 2 , adhesion to bEnd cells of all the H-2Kb-expressing clones was significantly lower than parental and Neo clones; Kb-G56 showed an intermediate behaviour.
This adhesive pattern is in accordance with the decreased experimental metastatic ability of H-2Kb-expressing transfectants (Table I ). The fact that Kb-G56 was significantly more adhesive and more metastatic than H-2Kb-expressing transfectants confirms that H-2 expression, rather than gene transfection per se, determined the inhibition of adhesion and of metastatic ability. Similarly to the results observed on bEnd, we found a significantly decreased adhesion of the H-2Kb transfected Figure 4 . Consistently with the results obtained using murine endothelial cells, B78H1 and Neo-C23 adhesion to resting HEC is higher than Kb-D34 cells. Adhesion to IL-1-activated HEC of B78H1 and Neo-C23 clones was significantly increased, as expected; on the contrary Kb-D34 cells did not enhance their adhesion after endothelial activation.
Adhesive interaction between melanoma and endothelial cells could be mediated by the binding of VLA-4 integrin receptor to the endothelial VCAM-1 counterpart. When cells were studied by cytofluorimetric analysis, control Neo cells were found to express OE4 subunit, although at a low level, whereas Kb-transfectant cells were almost x4-negative (Table  II) . This difference could not be attributed to a smaller dimension of Kb cells (Table II) clones expressed equal amounts of CD44 (Table II) and of the integrin subunit (data not shown). Adhesion assay was performed also in the presence of neutralising antibodies ( Figure 5 ): both anti-VCAM-1 and anti-136 subunit significantly inhibited ahdesion of Neo-C23 cells. The adhesion of Neo-C23 cells to endothelial cells was reduced by these neutralising antibodies to levels similar to H-2Kb transfectants, thus confirming the role played by the VLA-4/VCAM-1 interaction.
We then tested whether adhesion impairment of H-2Kb (Doherty et al., 1984) . Moreover MHC gene products can be involved in other functions potentially relevant to the metastatic process, such as cell-cell interactions (Bartlett & Edidin, 1978; Curtis & Rooney, 1979; Schirrmacher et al., 1980; Honda & Rostami, 1989) , homotypic cell adhesion (De Giovanni et al., 1991) and lectin-binding ability (Gorelik et al., 1991) . Our observations support the idea that H-2Kb glycoprotein expression profoundly affects the adhesive capacity of the cell, since a general decrease of tumour cell adhesion to different adhesive substrata was observed.
Several lines of evidence show that tumour cell interaction with extracellular matrix is relevant and related to the meta- (McCarthy et al., 1985; Nicolson, 1988; Ruoslahti & Giancotti, 1989; Albelda et al., 1990) . It has been shown that small RGD peptides, that can block by competition tumour cell integrin receptors for extracellular matrix (Hynes, 1987) , are able to reduce metastasis formation in vivo (Humphries et al., 1988; Saiki et al., 1989) .
Tumour cell adhesion to endothelial cells is also important for the metastatic process. Some authors found a positive correlation between cell adhesion to endothelial cells or to subendothelial matrix proteins and metastatic potential of tumour cell lines (Belloni & Tressler, 1989) and in particular of melanoma cells (including B16) (Chang et al., 1992; Kojima et al., 1992; Zhu et al., 1992) . In these papers, inhibition of both adhesion and metastasis was achieved by specific antibodies blocking different adhesion molecules. Here we showed that H-2Kb gene transfection in H-2-negative melanoma cells leads to both a decreased adhesion to endothelial cells and matrix proteins and to a dramatic reduction in the metastatic ability.
It has been previously reported that melanoma cells adhere more efficiently to IL-l-treated endothelium Martin-Padura et al., 1991) . This phenomenon was related to an increase in the number and incidence of artificial and spontaneous metastasis in IL-1-treated animals injected with melanoma cell lines (Giavazzi et al., 1990) . We reported here that, in contrast to the parental line and Neo clones, IL-1 treatment of the endothelium did not change the ability of H-2Kb transfectants to adhere to it.
The augmentation of melanoma adhesiveness to cytokinetreated HEC has been proven to be mediated by the recognition of the endothelial adhesive membrane protein VCAM-1 by melanoma counter receptor VLA-4 Martin-Padura et al., 1991) . Since M4 expression was indeed depressed in H-2Kb transfectants, it is likely that H-2Kb transfection impairs VLA-4/VCAM-1 typical recognition.
The mechanism underlying the profound depression of adhesion both to the endothelium and matrix proteins observed in H-2Kb transfectants cannot however be completely explained by an inhibition of a4I1 expression. This integrin can bind fibronectin but there is no evidence that it can interact with laminin and vitronectin. Furthermore VCAM-1 is expressed on resting endothelium only in minimal amounts (Rice et al., 1990) . This suggests that also other mechanisms play a role in H-2Kb_induced decrease of adhesive functions. Actin cytoskeletal organisation was not important since H-2Kb transfectants showed a normal microfilament pattern and spreading. A possibility could be that H-2 glycoproteins sterically hinder cell adhesion molecules required for melanoma adhesion to endothelial cells and to extracellular matrix. We are currently expanding the panel of available reagents recognising murine adhesion molecules, to obtain a comprehensive evaluation of the differences between Neo and Kb cells.
In conclusion our data indicate that expression of a single class I MHC gene can significantly alter tumour cell adhesive interactions. This alteration, along with the reported interference with the immune system of the hosts, could contribute to determine the decreased metastatic ability.
